BioSpace News Archive

HALO Precision Diagnostics (“HALO”), a leader in early disease detection using precision diagnostics, today announced the appointment of Thomas P. Slavin, M.D., as chief scientific officer.

AscellaHealth, a global healthcare and specialty pharmacy SP) solutions company, announces that CEO and President Belazi was invited to participate on a panel during the recent 2023 annual meeting of the Self Insurance Institute of America (SIIA) during a session entitled, “Specialty Pharmaceuticals: Remedy Pain Points for Self-Insured Employers.”

Immetas Therapeutics and GC Biopharma announced that they have entered into a research collaboration to discover and develop novel mRNA therapeutics for the treatment of a broad range of autoimmune diseases.

POXEL SA, a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis and rare metabolic disorders, announced that it will participate at two upcoming investor conferences.

Kuros Biosciences, a leader in next-generation bone graft technologies, provides an update on its commercial activities for the first nine months of 2023 and announces changes and a transition in responsibilities within the Executive Management.

Promore Pharma AB announced that the company has entered into voluntary liquidation and that the Swedish Companies Registration Office has appointed attorney Lars-Henrik Andersson as liquidator.

Alvotech announced that the US Food and Drug Administration has issued a complete response letter for Alvotech’s Biologics License Application for AVT04, a biosimilar candidate to Stelara®.

Photocure ASA, the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals has unveiled the results of its Hexvix® Phase III clinical trial in China.

Neoss Group, a leading innovator in dental implant solutions, is proud to announce that it has received EU Medical Device Regulation certification by its Notified Body, the BSI Group, the Netherlands B.V. for its implants and abutments.

So-Young International Inc., the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, announced that Mr. Min Yu, Mr. Xuejian Li, Mr. Charles Zhaoxuan Yang and Mr. Harry Jiannan Wang have tendered their resignations as directors of the Company for personal reasons, effective as of October 12, 2023.